Browse by Person

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 6.

Article

Andronis, L., Goranitis, I., Pirrie, S. et al. (19 more authors) (2016) Cost-effectiveness of zoledronic acid and strontium-89 as bone protecting treatments in addition to chemotherapy in patients with metastatic castrate-refractory prostate cancer: results from the TRAPEZE trial (ISRCTN 12808747). BJU International. ISSN 1464-4096

James, N.D., Pirrie, S.J., Pope, A.M. et al. (19 more authors) (2016) Clinical Outcomes and Survival Following Treatment of Metastatic Castrate-Refractory Prostate Cancer With Docetaxel Alone or With Strontium-89, Zoledronic Acid, or Both. JAMA Oncology, 2 (4). p. 493. ISSN 2374-2437

Ward, D.G., Baxter, L., Gordon, N.S. et al. (15 more authors) (2016) Multiplex PCR and Next Generation Sequencing for the Non-Invasive Detection of Bladder Cancer. PLOS ONE, 11 (2). e0149756-e0149756. ISSN 1932-6203

Bryan, R.T., Evans, T., Dunn, J.A. et al. (6 more authors) (2015) A Comparative Analysis of the Influence of Gender, Pathway Delays, and Risk Factor Exposures on the Long-term Outcomes of Bladder Cancer. European Urology Focus, 1 (1). 82 - 89.

Bryan, R.T., Shimwell, N.J., Wei, W. orcid.org/0000-0003-1288-6999 et al. (7 more authors) (2014) Urinary EpCAM in urothelial bladder cancer patients: characterisation and evaluation of biomarker potential. British Journal of Cancer, 110 (3). pp. 679-685. ISSN 0007-0920

Shimwell, N.J., Bryan, R.T., Wei, W. orcid.org/0000-0003-1288-6999 et al. (6 more authors) (2013) Combined proteome and transcriptome analyses for the discovery of urinary biomarkers for urothelial carcinoma. BRITISH JOURNAL OF CANCER, 108 (9). pp. 1854-1861. ISSN 0007-0920

This list was generated on Sat Aug 17 22:51:59 2019 BST.